A multi-institutional, prospective study of long-term follow-up for childhood cancer survivors

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036204

Enrollment

Unknown

Registered

2020-08-21

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancers

Interventions

Observation group:Nil

Eligibility

Sex/Gender

All

Age

2 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Cancer Survivors; 2. Patient after completion of all treatments over 2 years by August 31, 2020 and the oncologist in charge decided that the primary disease no longer required intervention; 3. Age <= 18 years.

Exclusion criteria

Exclusion criteria: nil

Design outcomes

Primary

Measure	Time frame
the cumulative incidence of late-effect;	—

Secondary

Measure	Time frame
To study the correlation between specific drug (platinum) exposure and ototoxicity with specific genetic abnormality;	—

Countries

China

Contacts

Public ContactCai Jiaoyang

Shanghai Children's Medical Center

caijiaoyang@scmc.com.cn+86 13621627180

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026